News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
Pharma middlemen propose regulatory changes to avoid Trump administration rules, Bloomberg News reports
The Pharmaceutical Care Management Association (PCMA), a key lobbying group for pharmacy middlemen, is drafting recommendations to present to the Centers for Medicare and Medicaid Services, Bloomberg News reported, citing a reviewed document.
Just 1 in 4 Americans believe Trump administration vaccine shifts are based on science, Reuters/Ipsos poll finds
The administration, while still in the process of setting new vaccination policies, has signaled that young and healthy people and pregnant women shouldn't get shots for the COVID-19 virus.
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
A federal judge ordered CVS Health's, opens new tab pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.
Ex-FTC lawyers form new firm targeting US antitrust enforcement ‘gaps’
Three former U.S. Federal Trade Commission lawyers and a U.S. attorney who resigned in January opened a new plaintiffs law firm on Tuesday focused on unfair competition, price discrimination and other antitrust law violations.
Bankrupt Rite Aid pursues rapid sale of pharmacy business
Bankrupt U.S. pharmacy chain Rite Aid on Wednesday received court approval to pursue a rapid-fire sale of its pharmacy business, with the company aiming to reach agreements with buyers and get a sale approved in just two weeks.
Oklahoma takes CVS Caremark to new PBM court over alleged underpayments
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for prescription drugs
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.